Radiomics in rectal cancer: current status of use and advances in research
Rectal cancer is a leading cause of morbidity and mortality among patients with malignant tumors in China. In light of the advances made in therapeutic approaches such as neoadjuvant therapy and total mesorectal excision, precise preoperative assessment has become crucial for developing a personaliz...
Saved in:
Main Authors: | Wei-Qin Huang, Ruo-Xuan Lin, Xiao-Hui Ke, Xiao-Hong Deng, Shi-Xiong Ni, Lina Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1470824/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computed Tomography Scan and Clinical-based Complete Response Prediction in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Machine Learning Approach
by: Seyyed Hossein Mousavie Anijdan, et al.
Published: (2024-12-01) -
Comparison of prognosis for T4b rectal cancer with different pelvic compartment involvement treated using neoadjuvant chemoradiotherapy and implications for refinement of the current T staging system: A retrospective cohort study
by: Yang-zi Zhang, et al.
Published: (2025-03-01) -
Identification of PET/CT radiomic signature for classification of locally recurrent rectal cancer: A network-based feature selection approach
by: Sara Dalmonte, et al.
Published: (2025-01-01) -
Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Masaaki Nishi, et al.
Published: (2025-01-01) -
Impact on CD4+ CD25High-CD127low regulatory T (Treg) cells of neoadjuvant therapy for rectal cancer patients
by: Liu Maoxi, et al.
Published: (2023-07-01)